Tenax Therapeutics TENX 深 滬
等待開盤 06-15 09:30:00 美东时间
11.48
+0.750
+6.99%
華盛通- 最 高12.30
- 今 開11.36
- 成交量 176.78万股
- 最 低 11.27
- 昨 收 10.73
- 總市值 3.05亿
- 52周最高 18.38
- 市盈率 靜 --
- 換手率 6.66%
- 52周最低 5.616
- 委 比 -79.10%
- 總股本 2652.52万
- 歷史最高 274560.00
- 量 比 2.25
- 振 幅 9.60%
- 歷史最低 4.63
- 每 手 1
- 風險率 3.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Adobe惨遭18家大行下调目标价！CFRA首予SpaceX(SPCX)"卖出"评级，目标价115美元
今日重点评级关注：Piper Sandler：维持Tenax Therapeutics"超配"评级，目标价从20美元升至50美元；Tigress Financial：维持优步"买入"评级，目标价从110美元升至115美元
今天 08:32
Piper Sandler Maintains Overweight on Tenax Therapeutics, Raises Price Target to $50
Piper Sandler analyst Yasmeen Rahimi maintains Tenax Therapeutics (NASDAQ:TENX) with a Overweight and raises the price target from $20 to $50.
06-13 00:38
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Caseys General Stores and Oracle on Friday. HIGHLIGHTS * Adobe Inc ADBE.O : Baird cuts target pri
06-12 15:34
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.58) by 39.66 percent. This is a 25 percent decrease over losses of $(0.28) per share from
05-12 19:08
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tenax Therapeutics granted stock options to purchase 657,500 shares to four new employees as inducements for their employment. The options vest over four years, with 25% vesting after one year and the rest vesting monthly thereafter. The awards were approved by the Board's Compensation Committee and granted outside the Company's equity incentive plan, in accordance with Nasdaq Listing Rule 5635(c)(4).
05-08 20:05
Tenax Therapeutics appoints Thomas Staab as chief financial officer
Tenax Therapeutics (TENX) has appointed Thomas Staab as chief financial officer, effective May 11, 2026, replacing Thomas McGauley. Staab brings over 25 years of leadership experience across managemen...
04-22 19:38
Tenax Therapeutics names new CFO
Tenax Therapeutics (TENX) appointed Thomas R. Staab II as CFo, effective May 11, 2026, replacing interim CFO Thomas McGauley. Staab brings more than 25 years of financial leadership experience in the ...
04-22 19:18
Tenax Therapeutics Files Prospectus For Offering $300M Securities
https://www.sec.gov/Archives/edgar/data/34956/000165495426002661/tennx_s3.htm
03-24 23:44
